Form D · Biotechnology

Orbit Genomics, Inc.

Boulder, CO · CIK 0002058369

Offering snapshot reported Jul 28, 2025 · SEC filing

Reported sold
$780K
Offering amount: $2M
Investors reported
15
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Jul 29, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$390K$780KMar 18, 2025: $530,000.00Mar 18, 2025Jul 28, 2025: $780,000.00Jul 28, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$530,000 → $780,000
  • Reported investors11 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2025Amendment$780,000$250,000vs Mar 18, 202515SEC filing
Mar 18, 2025Initial$530,000No comparison11SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-541191

Source: Form D, filed Jul 28, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Randy Berholtz Executive
Harold (Skip) Garner Director, Executive
Oerum Mikael Director
Julie Silber Director
Elizabeth (Dede) N Willis Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4665 Nautilus Ct S Ste 300
Boulder, CO, 80301